Treatment with adjuvant corneal cross-linking (CXL) does not seem to produce favourable results in patients with moderate filamentous fungal ulcers and may even lead to reduced visual acuity, a recent study has shown.
Serum 25-hydroxyvitamin D (25[OH]D) levels are significantly lower among patients with active uveitis than those with inactive uveitis and local population-based estimates, reports a study. In addition, vitamin D supplementation may help reduce uveitis activity, while sun exposure confers a beneficial effect to those with vitamin D deficiency.
Postprandial hyperglycaemia may increase the risk of incident diabetic retinopathy (DR) in patients with type 2 diabetes (T2D) independently of glycated haemoglobin (HbA1c) status, reports a new study.
The Hedgehog pathway inhibitor vismodegib appears to be effective in the treatment of locally advanced periocular basal cell carcinoma (BCC), with adverse events (AEs) that are mostly manageable, as reported in a recent study.
Use of cyclosporine A cationic emulsion 0.1% eye drops in the treatment of patients with severe active vernal keratoconjunctivitis is safe and yields improvements in keratitis, symptoms and quality of life that are maintained for up to 8 months, according to the results of a trial.
Aspirin use does not appear to result in progression of age-related macular degeneration (AMD) or its subtypes in either the Age-Related Eye Disease Study (AREDS) or AREDS2, a study has shown. Thus, there is no need to avoid aspirin use when it is medically indicated in AMD patients.
Refractive and visual outcomes, as well as neurodevelopmental outcomes, are similar at mean age of 1.5 years between children with prior history of intravitreal bevacizumab injection (IVB) and premature patients with retinopathy of prematurity (ROP) without treatment, as shown in a study.